Status:
COMPLETED
A Retrospective Evaluation of the Intraocular Pressure Spikes With Loteprednol and Loteprednol/Tobramycin
Lead Sponsor:
Allergan
Conditions:
Ocular Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Patient charts will be reviewed to evaluate the incidence of intraocular pressure spikes while on Loteprednol etabonate ophthalmic suspension 0.5%, Loteprednol etabonate (0.5%) and tobramycin (0.3%)
Eligibility Criteria
Inclusion
- Any patient who experienced an IOP spike while using Lotemax or Zylet will be included
Exclusion
- N/A
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00834171
Start Date
January 1 2009
End Date
December 1 2009
Last Update
September 26 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maclean, Virginia, United States